Initially, the pharmaceutical industry was built on the ability to identify, isolate, and purify chemical compounds with ...
Mycology reveals fungi's potential in mycoremediation, sustainable construction, and psilocybin research, addressing key ...
Biotechnology firm INmune Bio Inc. (NASDAQ: INMB) and photonic quantum developer Quantum Computing Inc. (NASDAQ: QUBT) have ...
Management will discuss business developments and outlook during the live call, with audio available on Nautilus' investor website at 8:30 a.m. Eastern.
The Defense Innovation Networking Group (D!NG) today announced that the submission window is officially open for the ...
With the support of a National Science Foundation grant, biology professor Heather Coleman looks to advance genetic research ...
The most difficult biological-security problem today is not simply the existence of biological weapons. It is the speed at ...
GAMMA SOLUTIONS introduces fractional CIO and CTO leadership to Atlanta, with founder Gilles-André Morin providing hands-on ...
The intensity of deep tech felt in UmekitaOn October 7th, I attended 'CONNECT—CO-creating New Change Together—,' a side event ...
MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that it ...
JPMorganreleased a report stating that, as global interest rates—particularly the yields on 10-year and 30-year U.S. Treasuries—rise, the risk-free rate used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results